BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38381245)

  • 1. MM165 - A Small Hybrid Molecule Modulates the Kynurenine Pathway and Attenuates Lipopolysaccharide-Induced Memory Deficits and Inflammation.
    Kotańska M; Łanocha M; Bednarski M; Marcinkowska M
    Neurochem Res; 2024 May; 49(5):1200-1211. PubMed ID: 38381245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study.
    Kruse JL; Cho JH; Olmstead R; Hwang L; Faull K; Eisenberger NI; Irwin MR
    Psychoneuroendocrinology; 2019 Nov; 109():104371. PubMed ID: 31325802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.
    Savitz J
    Curr Top Behav Neurosci; 2017; 31():249-267. PubMed ID: 27221627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.
    Larsson MK; Faka A; Bhat M; Imbeault S; Goiny M; Orhan F; Oliveros A; Ståhl S; Liu XC; Choi DS; Sandberg K; Engberg G; Schwieler L; Erhardt S
    Neurochem Res; 2016 Sep; 41(9):2243-55. PubMed ID: 27165635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
    Badawy AA
    Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia.
    Brum M; Nieberler M; Kehrwald C; Knopf K; Brunkhorst-Kanaan N; Etyemez S; Allers KA; Bittner RA; Slattery DA; McNeill RV; Reif A; Kittel-Schneider S
    World J Biol Psychiatry; 2023; 24(7):564-577. PubMed ID: 36648064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
    Fukushima T; Umino M; Sakamoto T; Onozato M
    Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
    Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
    Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome.
    Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central kynurenine pathway shift with age in women.
    de Bie J; Guest J; Guillemin GJ; Grant R
    J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects.
    Coccaro EF; Lee R; Fanning JR; Fuchs D; Goiny M; Erhardt S; Christensen K; Brundin L; Coussons-Read M
    Psychoneuroendocrinology; 2016 Sep; 71():189-96. PubMed ID: 27318828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
    Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
    Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
    Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
    J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism and Markers of Systemic Inflammation in People With Human Immunodeficiency Virus.
    Gelpi M; Ueland PM; Trøseid M; Mocroft A; Lebech AM; Ullum H; Midttun Ø; Lundgren J; Nielsen SD
    J Infect Dis; 2020 Jan; 221(3):419-427. PubMed ID: 31538186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.